China’s WuXi Biologics signs US$1.46B licensing deal with GSK by Editor | Jan 5, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, Science, Technology & Research, WORLD NEWS | 0 CHINA – WuXi Biologics, a leading global open-access biologics technology platform, has signed an... Read More